Morning Overview on MSN
Major review finds limited benefits from new Alzheimer’s drugs hailed as breakthroughs
For the roughly 6.9 million Americans living with Alzheimer’s disease, the arrival of drugs that target amyloid plaques in ...
Many people worry about memory loss as they get older. Dementia, including Alzheimer’s disease, is one of the most serious conditions affecting the brain. It slowly damages memory, thinking, and daily ...
Thinking about eating less meat for your health? A new study out of Sweden’s Karolinska Institutet suggests your genes may ...
But the pattern changed when the data was examined more closely. Men with higher sodium intake at the start showed a faster ...
Familiar music can reach important areas of the brain even in the late stages of dementia. Understanding how that works could ...
New findings show that a condition that affects 10% of US adults over 65 is likely increasing their risk of dementia by more ...
Does Alzheimer’s start in the muscles? Research reveals that motor neuron mutations disrupt the neuromuscular junction ...
It's the latest in a long-running dispute over the drugs, which some view as groundbreaking, while others say they leave much ...
On April 9, 2026, Emory University’s Rollins School of Public Health convened researchers, clinicians, and community leaders ...
UCF researchers have uncovered evidence that some movement-related symptoms of Alzheimer's disease may originate outside the ...
A study suggests that a blood test measuring the biomarker pTau217 can detect early signs of Alzheimer’s disease years before ...
A systematic review suggested that drugs targeting amyloid beta appeared to have no clinically meaningful positive effects, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results